Published in
Translational Neuroimmunology in Multiple Sclerosis, p. 217-233
DOI: 10.1016/b978-0-12-801914-6.00018-0
Links
Tools
Currently Approved Disease-Modifying Drugs
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 